Consumer Reports comes out with their recommendations on calcium channel blockers
Note that CCBs are not first-line medications for hypertension. Also note that Pfizer’s Norvasc, the world’s best-selling antihypertensive, is nowhere to be found in the recommendations.
Related posts:
- Pfizer gives up on cardiac drugs
- What are the recommended vitamins that patients should take?
- Dilemma and high school football
- More Russert analysis
- Should Singulair be sold over the counter?
- Selling drug samples
- Psychiatric drug cocktails for kids
KevinMD.com on Facebook
 
Follow on Twitter  
Subscribe





Comments on this entry are closed.